288 related articles for article (PubMed ID: 17658628)
1. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M
Arch Gerontol Geriatr; 2008; 46(2):181-90. PubMed ID: 17658628
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
Tomassini V; Pozzilli C; Onesti E; Pasqualetti P; Marinelli F; Pisani A; Fieschi C
J Neurol Sci; 2004 Mar; 218(1-2):103-8. PubMed ID: 14759641
[TBL] [Abstract][Full Text] [Related]
3. L-acetylcarnitine treatment of mental decline in the elderly.
Salvioli G; Neri M
Drugs Exp Clin Res; 1994; 20(4):169-76. PubMed ID: 7813389
[TBL] [Abstract][Full Text] [Related]
4. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
Janiri L; Martinotti G; Tonioni F; Ghelardini C; Nicolai R; Galeotti N; Mosconi L; Calvani M; Bartolini A; Iannoni E
Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503
[TBL] [Abstract][Full Text] [Related]
5. Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects.
Martinotti G; Andreoli S; Reina D; Di Nicola M; Ortolani I; Tedeschi D; Fanella F; Pozzi G; Iannoni E; D'Iddio S; Prof LJ
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):953-8. PubMed ID: 21256179
[TBL] [Abstract][Full Text] [Related]
6. [Effects of L-acetylcarnitine on mental deterioration in the aged: initial results].
Cipolli C; Chiari G
Clin Ter; 1990 Mar; 132(6 Suppl):479-510. PubMed ID: 2140973
[TBL] [Abstract][Full Text] [Related]
7. The effect of acetyl-L-carnitine administration on persons with Down syndrome.
Pueschel SM
Res Dev Disabil; 2006; 27(6):599-604. PubMed ID: 16621446
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.
Malaguarnera M; Bella R; Vacante M; Giordano M; Malaguarnera G; Gargante MP; Motta M; Mistretta A; Rampello L; Pennisi G
Scand J Gastroenterol; 2011 Jun; 46(6):750-9. PubMed ID: 21443422
[TBL] [Abstract][Full Text] [Related]
9. L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study.
Ciacci C; Peluso G; Iannoni E; Siniscalchi M; Iovino P; Rispo A; Tortora R; Bucci C; Zingone F; Margarucci S; Calvani M
Dig Liver Dis; 2007 Oct; 39(10):922-8. PubMed ID: 17693145
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of cognitive behavioral therapy for adolescents with chronic fatigue syndrome: long-term follow-up of a randomized, controlled trial.
Knoop H; Stulemeijer M; de Jong LW; Fiselier TJ; Bleijenberg G
Pediatrics; 2008 Mar; 121(3):e619-25. PubMed ID: 18310181
[TBL] [Abstract][Full Text] [Related]
11. Rehabilitation of older Chinese patients with different cognitive functions: how do they differ in outcome?
Luk JK; Chiu PK; Chu LW
Arch Phys Med Rehabil; 2008 Sep; 89(9):1714-9. PubMed ID: 18675394
[TBL] [Abstract][Full Text] [Related]
12. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
13. Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome.
Vermeulen RC; Scholte HR
Psychosom Med; 2004; 66(2):276-82. PubMed ID: 15039515
[TBL] [Abstract][Full Text] [Related]
14. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U
Int J Clin Pharmacol Res; 1990; 10(1-2):75-9. PubMed ID: 2201659
[TBL] [Abstract][Full Text] [Related]
15. Short-term effects of aerobic exercise on functional capacity, fatigue, and quality of life in patients with post-polio syndrome.
Oncu J; Durmaz B; Karapolat H
Clin Rehabil; 2009 Feb; 23(2):155-63. PubMed ID: 19164403
[TBL] [Abstract][Full Text] [Related]
16. A review of nutrients and botanicals in the integrative management of cognitive dysfunction.
Kidd PM
Altern Med Rev; 1999 Jun; 4(3):144-61. PubMed ID: 10383479
[TBL] [Abstract][Full Text] [Related]
17. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
Malaguarnera M; Gargante MP; Cristaldi E; Vacante M; Risino C; Cammalleri L; Pennisi G; Rampello L
Dig Dis Sci; 2008 Nov; 53(11):3018-25. PubMed ID: 18357530
[TBL] [Abstract][Full Text] [Related]
18. Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6).
Erkinjuntti T; Gauthier S; Bullock R; Kurz A; Hammond G; Schwalen S; Zhu Y; Brashear R
J Psychopharmacol; 2008 Sep; 22(7):761-8. PubMed ID: 18308781
[TBL] [Abstract][Full Text] [Related]
19. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
20. Physical fitness and cognitive function in an 85-year-old community-dwelling population.
Takata Y; Ansai T; Soh I; Kimura Y; Yoshitake Y; Sonoki K; Awano S; Kagiyama S; Yoshida A; Nakamichi I; Hamasaki T; Torisu T; Toyoshima K; Takehara T
Gerontology; 2008; 54(6):354-60. PubMed ID: 18460865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
